Skip to main content
HUTCHMED (China) Limited (HKG:0013)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
24.50
-0.65 (-2.58%)
Apr 3, 2025, 4:08 PM HKT

HUTCHMED (China) Revenue

In the year 2024, HUTCHMED (China) had annual revenue of $630.20M USD, down -24.80%. HUTCHMED (China) had revenue of $324.52M in the half year ending December 31, 2024, with 44.64% growth.

Revenue
$630.20M
Revenue Growth
-24.80%
P/S Ratio
n/a
Revenue / Employee
$347.99K
Employees
1,811
Market Cap
20.59B HKD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024630.20M-207.80M-24.80%
Dec 31, 2023838.00M411.59M96.52%
Dec 31, 2022426.41M70.28M19.73%
Dec 31, 2021356.13M128.15M56.21%
Dec 31, 2020227.98M23.09M11.27%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BeiGene 29.60B
Hansoh Pharmaceutical Group Company 13.05B
WuXi Biologics 19.87B
JD Health International 61.89B
Innovent Biologics 10.03B
Akeso 2.26B
Alibaba Health Information Technology 31.39B
Sichuan Kelun-Biotech Biopharmaceutical 2.06B
Revenue Rankings

HUTCHMED (China) News

More News